JP2009502803A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2009502803A5 JP2009502803A5 JP2008522960A JP2008522960A JP2009502803A5 JP 2009502803 A5 JP2009502803 A5 JP 2009502803A5 JP 2008522960 A JP2008522960 A JP 2008522960A JP 2008522960 A JP2008522960 A JP 2008522960A JP 2009502803 A5 JP2009502803 A5 JP 2009502803A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- polyethylene glycol
- polypeptide
- seq
- encoded
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US70090505P | 2005-07-20 | 2005-07-20 | |
| PCT/US2006/028215 WO2007012033A2 (en) | 2005-07-20 | 2006-07-20 | Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2009502803A JP2009502803A (ja) | 2009-01-29 |
| JP2009502803A5 true JP2009502803A5 (https=) | 2009-09-03 |
Family
ID=37600989
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2008522960A Pending JP2009502803A (ja) | 2005-07-20 | 2006-07-20 | Ｉｌ−２８およびｉｌ−２９のシステイン欠失変異体、ならびにそれを用いる抗ウイルス法 |
Country Status (7)
| Country | Link |
|---|---|
| US (3) | US20070053933A1 (https=) |
| EP (1) | EP1912668A2 (https=) |
| JP (1) | JP2009502803A (https=) |
| AU (1) | AU2006269908A1 (https=) |
| CA (1) | CA2616122A1 (https=) |
| IL (1) | IL188350A0 (https=) |
| WO (1) | WO2007012033A2 (https=) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7038032B2 (en) | 2001-04-20 | 2006-05-02 | Zymogenetics, Inc. | Cytokine protein family |
| CA2503305A1 (en) | 2002-10-23 | 2004-05-06 | Zymogenetics, Inc. | Methods for treating viral infection using il-28 and il-29 |
| EP2251352A1 (en) * | 2003-08-07 | 2010-11-17 | ZymoGenetics, L.L.C. | Homogeneous preparations of IL-28 and IL-29 |
| JP4896005B2 (ja) | 2004-04-02 | 2012-03-14 | ザイモジェネティクス リミテッド ライアビリティ カンパニー | Ｉｌ−２８およびｉｌ−２９システイン変異体を用いるウイルス感染を治療するための方法 |
| AU2006272937A1 (en) * | 2005-07-20 | 2007-02-01 | Bristol-Myers Squibb Company | Use of truncated cysteine IL28 and IL29 mutants to treat cancers and autoimmune disorders |
| EP1912668A2 (en) * | 2005-07-20 | 2008-04-23 | ZymoGenetics, Inc. | Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
| ME00485B (me) * | 2005-10-07 | 2011-10-10 | Zoetis Services Llc | VAKCINE l METODE LIJEČENJA INFLUENCE KOD CANINA |
| AU2009255994B2 (en) * | 2008-06-05 | 2014-07-17 | Bristol-Myers Squibb Company | Use of pegylated Type III Interferons for the treatment of hepatitis C |
| US20100093618A1 (en) * | 2008-10-15 | 2010-04-15 | Quinto Ileana | Polypeptide capable of inhibiting hiv-1 transcription and replication and uses thereof |
| EP2350124A1 (en) * | 2008-11-20 | 2011-08-03 | Zymogenetics, Inc. | Il-29 mutants and uses thereof |
| US20100316604A1 (en) * | 2009-04-21 | 2010-12-16 | Asterion Limited | Interferon lambda fusion polypeptides |
| US11311519B2 (en) | 2014-05-01 | 2022-04-26 | Eiger Biopharmaceuticals, Inc. | Treatment of hepatitis delta virus infection |
| US10076512B2 (en) | 2014-05-01 | 2018-09-18 | Eiger Biopharmaceuticals, Inc. | Treatment of hepatitis delta virus infection |
| CN103923209B (zh) * | 2014-05-13 | 2016-06-22 | 北京凯因科技股份有限公司 | 一种Lambda干扰素突变体及聚乙二醇衍生物 |
| CN105085658B (zh) * | 2014-05-14 | 2019-12-24 | 杭州先为达生物科技有限公司 | 一种白细胞介素29突变体及聚乙二醇衍生物 |
| WO2016172342A1 (en) | 2015-04-21 | 2016-10-27 | Eiger Biopharmaceuticals, Inc. | Pharmaceutical compositions comprising lonafarnib and ritonavir |
| JP7674628B2 (ja) | 2016-02-19 | 2025-05-12 | イーアイティー・ファーマ・インコーポレイテッド | インターフェロンラムダによるデルタ型肝炎ウイルス感染の処置 |
| CN112694526B (zh) * | 2020-05-27 | 2023-01-20 | 杭州先为达生物科技有限公司 | 一种白细胞介素29突变体蛋白 |
| WO2024241086A1 (en) * | 2023-05-24 | 2024-11-28 | Ambrx, Inc. | Pegylated bovine interferon lambda and methods of use thereof |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4853332A (en) * | 1982-10-19 | 1989-08-01 | Cetus Corporation | Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of biologically active proteins |
| US5206344A (en) * | 1985-06-26 | 1993-04-27 | Cetus Oncology Corporation | Interleukin-2 muteins and polymer conjugation thereof |
| US6468776B1 (en) * | 2000-03-03 | 2002-10-22 | Zymogenetics, Inc. | Human serine protease |
| DE60135393D1 (de) * | 2000-06-30 | 2008-09-25 | Zymogenetics Inc | Allelische Variante des Interferon-ähnlichen Proteins Zcyto21 |
| US6822082B2 (en) * | 2000-06-30 | 2004-11-23 | Zymogenetics, Inc. | Polynucleotides for mammalian secreted protein, Z1055G2P |
| US7038032B2 (en) * | 2001-04-20 | 2006-05-02 | Zymogenetics, Inc. | Cytokine protein family |
| CN1659274A (zh) * | 2002-04-19 | 2005-08-24 | 津莫吉尼蒂克斯公司 | 细胞因子受体 |
| CA2503305A1 (en) * | 2002-10-23 | 2004-05-06 | Zymogenetics, Inc. | Methods for treating viral infection using il-28 and il-29 |
| EP2251352A1 (en) * | 2003-08-07 | 2010-11-17 | ZymoGenetics, L.L.C. | Homogeneous preparations of IL-28 and IL-29 |
| JP4896005B2 (ja) * | 2004-04-02 | 2012-03-14 | ザイモジェネティクス リミテッド ライアビリティ カンパニー | Ｉｌ−２８およびｉｌ−２９システイン変異体を用いるウイルス感染を治療するための方法 |
| JP2008508310A (ja) * | 2004-07-29 | 2008-03-21 | ザイモジェネティクス， インコーポレイテッド | がんおよび自己免疫障害を治療するためのｉｌ−２８およびｉｌ−２９の使用法 |
| EP1912668A2 (en) * | 2005-07-20 | 2008-04-23 | ZymoGenetics, Inc. | Il28 and il29 truncated cysteine mutants and antiviral methods of using same |
| AU2006272937A1 (en) * | 2005-07-20 | 2007-02-01 | Bristol-Myers Squibb Company | Use of truncated cysteine IL28 and IL29 mutants to treat cancers and autoimmune disorders |
| CA2625208A1 (en) * | 2005-10-04 | 2007-04-12 | Zymogenetics, Inc. | Production and purification of il-29 |
-
2006
- 2006-07-20 EP EP06787996A patent/EP1912668A2/en not_active Withdrawn
- 2006-07-20 US US11/458,945 patent/US20070053933A1/en not_active Abandoned
- 2006-07-20 JP JP2008522960A patent/JP2009502803A/ja active Pending
- 2006-07-20 AU AU2006269908A patent/AU2006269908A1/en not_active Abandoned
- 2006-07-20 WO PCT/US2006/028215 patent/WO2007012033A2/en not_active Ceased
- 2006-07-20 CA CA002616122A patent/CA2616122A1/en not_active Abandoned
-
2007
- 2007-12-24 IL IL188350A patent/IL188350A0/en unknown
-
2011
- 2011-03-07 US US13/042,083 patent/US20110182852A1/en not_active Abandoned
- 2011-12-20 US US13/331,000 patent/US20120114590A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2009502803A5 (https=) | ||
| JP2009502800A5 (https=) | ||
| JP2008540565A5 (https=) | ||
| JP2010534684A5 (https=) | ||
| WO2010033220A3 (en) | Modified therapeutics peptides, methods of their preparation and use | |
| JP2010505444A5 (https=) | ||
| JP2013515057A5 (https=) | ||
| JP2003503454A5 (https=) | ||
| JP2013507132A5 (https=) | ||
| JP2012176978A5 (https=) | ||
| NZ580686A (en) | Modified interferon beta polypeptides and their uses | |
| EP2174668A3 (en) | Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis | |
| JP2010534486A5 (https=) | ||
| EP2455459A3 (en) | Lipase variants for pharmaceutical use | |
| JP2010166916A5 (https=) | ||
| CO6351745A2 (es) | Polipéptidos g-csf bovinos modificados y sus usos | |
| EA201200398A1 (ru) | Полипептиды с оксидоредуктазной активностью и их применение | |
| WO2007125501A3 (en) | Liquid compositions comprising phenylephrine and acetaminophen and their use for the treatment of respiratory illness | |
| JP2009504138A5 (https=) | ||
| JP2014513941A5 (https=) | ||
| JP2009256608A5 (https=) | ||
| JP2011528334A5 (https=) | ||
| MX2010001243A (es) | Composicion anti-inflamatoria. | |
| JP2008517059A5 (https=) | ||
| JP2009534017A5 (https=) |